Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Nature Reviews. Urology
|
March 20, 2021
Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer
Sarah W S Ng, Alexander W Wyatt
JCO Precision Oncology
|
May 4, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer
Nicolette M Fonseca, Kim Van der Eecken, Cameron Herberts, et al.
Frontiers in Systems Biology
|
August 14, 2025
Forecasting SARS-CoV-2 spike protein evolution from small data by deep learning and regression
Samuel King, Xinyi E Chen, Sarah W S Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Sofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, et al.
NPJ Precision Oncology
|
March 14, 2023
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes
Elie J Ritch, Cameron Herberts, Evan W Warner, et al.
Nature Medicine
|
May 27, 2025
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial
Edmond M Kwan, Sarah W S Ng, Sofie H Tolmeijer, et al.
Nature
|
July 21, 2022
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
Cameron Herberts, Matti Annala, Joonatan Sipola, et al.
Cancer Research
|
December 9, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer
Joonatan Sipola, Aslı D Munzur, Edmond M Kwan, et al.
Nature Cancer
|
January 4, 2024
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
Evan W Warner, Kim Van der Eecken, Andrew J Murtha, et al.
European Urology Oncology
|
October 1, 2025
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis
Karan Parekh, Kim van der Zande, Sarah W S Ng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Nature Reviews. Urology
|
March 20, 2021
Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer
Sarah W S Ng, Alexander W Wyatt
JCO Precision Oncology
|
May 4, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer
Nicolette M Fonseca, Kim Van der Eecken, Cameron Herberts, et al.
Frontiers in Systems Biology
|
August 14, 2025
Forecasting SARS-CoV-2 spike protein evolution from small data by deep learning and regression
Samuel King, Xinyi E Chen, Sarah W S Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Sofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, et al.
NPJ Precision Oncology
|
March 14, 2023
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes
Elie J Ritch, Cameron Herberts, Evan W Warner, et al.
Nature Medicine
|
May 27, 2025
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial
Edmond M Kwan, Sarah W S Ng, Sofie H Tolmeijer, et al.
Nature
|
July 21, 2022
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
Cameron Herberts, Matti Annala, Joonatan Sipola, et al.
Cancer Research
|
December 9, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer
Joonatan Sipola, Aslı D Munzur, Edmond M Kwan, et al.
Nature Cancer
|
January 4, 2024
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
Evan W Warner, Kim Van der Eecken, Andrew J Murtha, et al.
European Urology Oncology
|
October 1, 2025
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis
Karan Parekh, Kim van der Zande, Sarah W S Ng, et al.
Page
of 2